This databook provides key data and information on the Other OTC Healthcare Products Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
Other OTC healthcare products category was valued at PKR4,617.8m ($65.6m) in 2009, representing a CAGR of 9.9% since 2004.
By the end of 2014, other OTC healthcare products category will be worth PKR6,345.8m ($90.1m), with an expected CAGR of 6.6% between 2009 and 2014.
Other OTC healthcare products market was led by rectal medications (representing 43.3% of the total value) followed by motion sickness and eye / ear drops, with a 25.7% and 13.6% market share, respectively. Anti-smoking aids and sleeping aids constitute the remaining segments with a 9.4% and 8% market share, respectively.
GlaxoSmithKline Plc is the market leader with a 6.8% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in Pakistan (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements